Carefx Corporation – Trademark Portfolio

Entity Type: 03

Carefx Corporation holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FUSIONFX. The owner is based in Scottsdale, AZ.

8767 E. Via de Ventura, Suite 390

Scottsdale, AZ 85258

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Carefx Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Carefx Corporation have?

Carefx Corporation has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.

What trademark classes does Carefx Corporation file in?

Carefx Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Carefx Corporation's most well-known trademarks?

Carefx Corporation's registered trademark portfolio includes well-known marks such as FUSIONFX. These are among 1 currently registered trademark in the portfolio.

What is Carefx Corporation's trademark registration success rate?

Carefx Corporation has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.